NEW YORK (GenomeWeb News) - Lumera said today that it has discontinued operations for its Plexera proteomics subsidiary in conjunction with an agreement to merge with GigOptix, a privately held developer of integrated circuits for optical communication systems.
The combined company will be listed on the Nasdaq market under the name GigOptix. GigOptix’s CEO and chairman, Avi Katz, will serve as CEO and chairman of the company following the merger.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.